Experts in diabetes, pain and health services from the Worldwide Initiative for Diabetes Education recommend spinal cord stimulation when symptoms aren't responsive to first- or second-line therapies ...
The FDA has approved Nevro Corp's (NYSE: NVRO) Senza system for treating chronic pain associated with painful diabetic neuropathy (PDN). The approval is specific to Nevro's 10 kHz stimulation. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results